Age-related differences in heparin response

被引:88
作者
Ignjatovic, Vera
Furmedge, Janine
Newall, Fiona
Chan, Anthony
Berry, Leslie
Fong, Chrystal
Cheng, Ken
Monagle, Paul
机构
[1] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[2] Royal Childrens Hosp, Dept Haematol, Parkville, Vic 3052, Australia
[3] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
[4] McMaster Univ, Dept Paediat, Henderson Res Ctr, Hamilton, ON, Canada
基金
英国医学研究理事会;
关键词
Anti-Factor Xa; Anti-Factor IIa; APTT; children; heparin;
D O I
10.1016/j.thromres.2005.11.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Major physiological differences in the coagulation system throughout childhood, compared to adults, are well documented. However, the impact of this on anticoagulant drugs is unknown. This study aimed to determine whether heparin therapeutic range determination is affected by the age of plasma donors and whether age-specific therapeutic ranges for heparin therapy may need to be considered in the clinical setting. Materials and methods: Plasma samples were obtained from healthy children and adults, and pooled into age-specific pools. These were spiked with different concentrations of heparin and APTT, Anti-Factor Xa and Anti-Factor IIa were measured using standard techniques. The experiments were repeated using three separate plasma pools, and results expressed as means with standard deviations. Results and conclusions: The results show clear age-related differences in APTT for the same Anti-Factor Xa heparin concentration. The differences were more pronounced in younger children, with higher APTT for same Anti-Factor Xa. The Anti-Factor IIa activity of heparin for a given Anti-Factor Xa activity also differed between age-specific plasma pools.
引用
收藏
页码:741 / 745
页数:5
相关论文
共 8 条
[1]  
ANDREW M, 1988, BLOOD, V72, P1651
[2]   DEVELOPMENT OF THE HUMAN COAGULATION SYSTEM IN THE FULL-TERM INFANT [J].
ANDREW, M ;
PAES, B ;
MILNER, R ;
JOHNSTON, M ;
MITCHELL, L ;
TOLLEFSEN, DM ;
POWERS, P .
BLOOD, 1987, 70 (01) :165-172
[3]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[4]   Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [J].
Hirsh, J ;
Raschke, R .
CHEST, 2004, 126 (03) :188S-203S
[5]  
MONAGLE P, 2003, NATHAN OSKIS HEMATOL, V1, P121
[6]  
MONAGLE P, 2003, FVEATL NEONATAL PHYS, V2, P1435
[7]   Heparin-induced thrombocytopenia in children [J].
Newall, F ;
Barnes, C ;
Ignjatovic, V ;
Monagle, P .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2003, 39 (04) :289-292
[8]   Paediatric clinical trials: Redressing the imbalance [J].
Schreiner, MS .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (12) :949-961